Profilo
Jennifer Dudinak served as the Senior Vice President-Global Regulatory Affairs at Celgene Corp.
from 2018 to 2019.
She received her undergraduate and doctorate degrees from Rutgers University, Camden.
Precedenti posizioni note di Jennifer Dudinak
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | General Counsel | 01/10/2019 |
Formazione di Jennifer Dudinak
| Rutgers University, Camden | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Dudinak
